| Patent | Date |
|---|
Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor
Grant 11,446,273 - Yamamoto , et al. September 20, 2 | 2022-09-20 |
Ophthalmic aqueous composition
Grant 11,439,652 - Endo , et al. September 13, 2 | 2022-09-13 |
Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
Grant 11,419,880 - Kato , et al. August 23, 2 | 2022-08-23 |
Use of sirolimus to treat exudative age-related macular degeneration with persistent edema
Grant 11,400,080 - Maturi August 2, 2 | 2022-08-02 |
Lipoic Acid Prodrug
App 20220151989 - KATO; Masatomo ; et al. | 2022-05-19 |
Medicament for preventing and/or treating dry eye
Grant 11,331,322 - Oki , et al. May 17, 2 | 2022-05-17 |
Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound
Grant 11,331,311 - Kirihara , et al. May 17, 2 | 2022-05-17 |
Antiseptic agent comprising meglumine or salt thereof
Grant 11,324,829 - Fujisawa , et al. May 10, 2 | 2022-05-10 |
Optical Probe
App 20220126112 - KAMIKATANO; Mitsuru ; et al. | 2022-04-28 |
Ursodeoxycholic Acid-containing Agent For Treating Or Preventing Presbyopia
App 20220096497 - KATO; Masatomo ; et al. | 2022-03-31 |
Sealed preparation container and use for same
Grant 11,285,081 - Mudumba , et al. March 29, 2 | 2022-03-29 |
Ursodeoxycholic Acid-containing Agent For Treating Or Preventing Presbyopia
App 20220072012 - KATO; Masatomo ; et al. | 2022-03-10 |
Agent Containing 4-phenylbutyrate, For Preventing Or Treating Presbyopia
App 20220062209 - KATO; Masatomo ; et al. | 2022-03-03 |
Ophthalmic Composition Containing Diquafosol Or Salt Thereof, Vinyl-based Polymer And Cellulose-based Polymer
App 20220054520 - MORISHIMA; Kenji ; et al. | 2022-02-24 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20220054466 - SHAMS; Naveed ; et al. | 2022-02-24 |
Ophthalmological Diagnosis Device
App 20220044403 - AYATSUKA; Yuji ; et al. | 2022-02-10 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant 11,197,849 - Shams , et al. December 14, 2 | 2021-12-14 |
Ophthalmic solution comprising Diquafosol
Grant 11,166,974 - Sakatani , et al. November 9, 2 | 2021-11-09 |
Agent For Treating Or Preventing Glaucoma Including A Sulfonamide Compound And Another Drug
App 20210330654 - KIRIHARA; Tomoko ; et al. | 2021-10-28 |
Sustained-release pharmaceutical composition
Grant 11,090,296 - Okabe , et al. August 17, 2 | 2021-08-17 |
High-affinity Anti-vegf Antibody
App 20210228700 - MURAKAMI; Yasufumi ; et al. | 2021-07-29 |
Accurate, Precise Microliter Dosing Syringe
App 20210178080 - SHETTY; Gautam N. ; et al. | 2021-06-17 |
Intratumoral administration of sirolimus for treatment of prostate cancer
Grant 11,013,731 - Kundu , et al. May 25, 2 | 2021-05-25 |
High-affinity anti-VEGF antibody
Grant 11,007,259 - Murakami , et al. May 18, 2 | 2021-05-18 |
Antibody inhibiting binding of VEGF to NRP1
Grant 11,008,387 - Murakami , et al. May 18, 2 | 2021-05-18 |
Therapeutic Agent For Dry Eye Characterized By Being Applied To Eye Of Dry Eye Patient Wearing Soft Contact Lens
App 20210128601 - OSHITA; Yoshihiro ; et al. | 2021-05-06 |
Composition For Preventing And/or Improving Brain Dysfunction Comprising A Lutein Or Salt Thereof And A Plant Product Of The Genus Trapa
App 20210128492 - ITO; Takeshi ; et al. | 2021-05-06 |
Omidenepag Combination
App 20210106569 - FUWA; Masahiro ; et al. | 2021-04-15 |
Drug containing pyridylaminoacetic acid compound
Grant 10,940,144 - Taniguchi , et al. March 9, 2 | 2021-03-09 |
Method And Composition For Treating Ocular Hypertension And Glaucoma
App 20210059931 - REUNAMAKI; Timo ; et al. | 2021-03-04 |
Prophylactic Agent And/or Therapeutic Agent For Cataract, Medicinal Composition For Preventing And/or Treating Cataract, Use Of Ppar Activator For Producing Same, And Eyedrops
App 20210059997 - OKI; Masaya ; et al. | 2021-03-04 |
Therapeutic agent for dry eye characterized by being applied to eye of dry eye patient wearing soft contact lens
Grant 10,918,656 - Oshita , et al. February 16, 2 | 2021-02-16 |
Method For Changing Condition Of Eyelid Of Hairless Animal
App 20210011004 - MIYAKE; Hideki ; et al. | 2021-01-14 |
Ophthalmic Composition Comprising Diquafosol And Cationic Polymer
App 20210000844 - TAKAHASHI; Kyohei ; et al. | 2021-01-07 |
Method and composition for treating ocular hypertension and glaucoma
Grant 10,864,159 - Reunamaki , et al. December 15, 2 | 2020-12-15 |
Depot Formulations
App 20200383957 - TAMRAZ; Wilma ; et al. | 2020-12-10 |
Depot Formulations
App 20200352852 - TAMRAZ; Wilma ; et al. | 2020-11-12 |
Ophthalmic Aqueous Composition
App 20200352964 - ENDO; Yoko ; et al. | 2020-11-12 |
Pharmaceutical Composition Containing Pyridylaminoacetic Acid Compound
App 20200353084 - ENDO; Yoko | 2020-11-12 |
Pharmaceutical Preparation Containing Pyridyl Aminoacetic Acid Compound
App 20200345713 - Kawata; Hisashi ; et al. | 2020-11-05 |
MEDICAMENT COMPRISING COMBINATION OF SEPETAPROST AND Rho-ASSOCIATED COILED-COIL CONTAINING PROTEIN KINASE INHIBITOR
App 20200316009 - YAMAMOTO; Yasuko ; et al. | 2020-10-08 |
Aqueous ophthalmic solution
Grant 10,786,526 - Inagaki , et al. September 29, 2 | 2020-09-29 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20200289483 - SHAMS; Naveed ; et al. | 2020-09-17 |
Pharmaceutical composition containing pyridylaminoacetic acid compound
Grant 10,765,750 - Endo Sep | 2020-09-08 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant RE48,183 - Shams , et al. Sep | 2020-09-01 |
Ophthalmic aqueous composition
Grant 10,758,554 - Endo , et al. Sep | 2020-09-01 |
Lens Holder And Injector For Intraocular Lens
App 20200268507 - MATSUMOTO; Kazuma ; et al. | 2020-08-27 |
Therapeutic Agent For Dry Eye Characterized By Being Applied To Eye Of Dry Eye Patient Wearing Soft Contact Lens
App 20200254000 - Kind Code | 2020-08-13 |
Therapeutic agent for dry eye characterized by being applied to eye of dry eye patient wearing soft contact lens
Grant 10,729,712 - Oshita , et al. | 2020-08-04 |
Ophthalmic Solution Comprising Diquafosol
App 20200215093 - Sakatani; Akiko ; et al. | 2020-07-09 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant 10,702,511 - Shams , et al. | 2020-07-07 |
Prophylactic And/or Therapeutic Agent Containing Pyridylaminoacetic Acid Compound
App 20200206200 - KIRIHARA; Tomoko ; et al. | 2020-07-02 |
Drug Containing Pyridylaminoacetic Acid Compound
App 20200188377 - TANIGUCHI; TAKAZUMI ; et al. | 2020-06-18 |
Depot formulations
Grant 10,682,340 - Tamraz , et al. | 2020-06-16 |
Depot formulations
Grant 10,668,011 - Tamraz , et al. | 2020-06-02 |
High-affinity Anti-vegf Antibody
App 20200165330A1 - | 2020-05-28 |
Antiseptic Agent Comprising Meglumine Or Salt Thereof
App 20200147222 - Fujisawa; Toyomi ; et al. | 2020-05-14 |
Agent For Preventing Myopia, Treating Myopia, And/or Preventing Myopia Progression Comprising Tiotropium As Active Ingredient
App 20200147098A1 - | 2020-05-14 |
Use Of Sirolimus To Treat Exudative Age-related Macular Degeneration With Persistent Edema
App 20200147056 - MATURI; Raj K. | 2020-05-14 |
Ophthalmic solution comprising diquafosol
Grant 10,632,139 - Sakatani , et al. | 2020-04-28 |
Pyridylaminoacetic Acid Compound And Polyoxyethylene Castor Oil-containing Pharmaceutical Composition
App 20200113880 - ENDO; Yoko | 2020-04-16 |
Agent For Treating Or Preventing Glaucoma Including A Sulfonamide Compound And Another Drug
App 20200085804 - KIRIHARA; Tomoko ; et al. | 2020-03-19 |
Pharmaceutical Composition Containing Pyridylaminoacetic Acid Compound
App 20200046839 - ENDO; Yoko | 2020-02-13 |
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof
App 20190359577 - KAWASHIMA; Kenji ; et al. | 2019-11-28 |
Sealed Preparation Container And Use For Same
App 20190358128 - MUDUMBA; Sreenivasu ; et al. | 2019-11-28 |
Pharmaceutical composition containing pyridylaminoacetic acid compound
Grant 10,485,872 - Endo Nov | 2019-11-26 |
Intratumoral Administration Of Sirolimus For Treatment Of Prostate Cancer
App 20190343821 - KUNDU; Aishwarya ; et al. | 2019-11-14 |
Antibody Inhibiting Binding Of Vegf To Nrp1
App 20190322732 - MURAKAMI; Yasufumi ; et al. | 2019-10-24 |
[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof
Grant 10,435,379 - Kawashima , et al. O | 2019-10-08 |
Method Of Predicting Responsiveness Of Wet Amd Patient To Anti-vegf Therapy
App 20190293661 - Shibagaki; Keiichi ; et al. | 2019-09-26 |
Therapeutic Agent For Meibomian Dysfunction
App 20190255026 - MIYAKE; Hideki ; et al. | 2019-08-22 |
Aqueous Ophthalmic Solution
App 20190209599 - INAGAKI; Koji ; et al. | 2019-07-11 |
Aqueous ophthalmic solution
Grant 10,278,985 - Inagaki , et al. | 2019-05-07 |
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof
App 20190106393 - KAWASHIMA; Kenji ; et al. | 2019-04-11 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20190105310 - SHAMS; Naveed ; et al. | 2019-04-11 |
Test Kit And Test Method For Atrophic Age-related Macular Degeneration
App 20190106748 - Matsushita; Tokiyoshi | 2019-04-11 |
Pharmaceutical Composition Containing Pyridylaminoacetic Acid Compound
App 20190060459 - ENDO; Yoko | 2019-02-28 |
Injector for intraocular lens
Grant 10,206,815 - Yamada , et al. Feb | 2019-02-19 |
Pharmaceutical Composition Including Dorzolamide And Brimonidine
App 20190038598 - UMEZAKI; Shinya | 2019-02-07 |
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof
Grant 10,189,796 - Kawashima , et al. Ja | 2019-01-29 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant 10,179,127 - Shams , et al. Ja | 2019-01-15 |
Fungal keratitis prophylactic or therapeutic agent
Grant 10,166,217 - Zhang , et al. J | 2019-01-01 |
Ophthalmic Solution Comprising Diquafosol
App 20180353531 - Sakatani; Akiko ; et al. | 2018-12-13 |
Ophthalmic Solutions
App 20180353518 - Morishima; Kenji ; et al. | 2018-12-13 |
Pharmaceutical composition containing pyridylaminoacetic acid compound
Grant 10,149,908 - Endo Dec | 2018-12-11 |
Method for changing condition of an eyelid for evaluation of an eyelid disease involving plugging of meibomian gland orifices and/or telangiectasia by administration of complete freund's adjuvant
Grant 10,143,761 - Miyake , et al. De | 2018-12-04 |
Liquid Formulations For Treatment Of Diseases Or Conditions
App 20180311152 - MUDUMBA; Sreenivasu ; et al. | 2018-11-01 |
Method And Composition For Treating Ocular Hypertension And Glaucoma
App 20180289618 - REUNAMAKI; Timo ; et al. | 2018-10-11 |
Fungal Keratitis Prophylactic Or Therapeutic Agent
App 20180271841 - ZHANG; Jinzhong ; et al. | 2018-09-27 |
Ophthalmic solution comprising diquafosol
Grant 10,071,113 - Sakatani , et al. September 11, 2 | 2018-09-11 |
[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy Compound Or Salt Thereof
App 20180244633 - KAWASHIMA; Kenji ; et al. | 2018-08-30 |
Method For Changing Condition Of Eyelid Of Hairless Animal
App 20180246081 - MIYAKE; Hideki ; et al. | 2018-08-30 |
Prophylactic And/or Therapeutic Agent Containing Pyridylaminoacetic Acid Compound
App 20180200239 - KIRIHARA; Tomoko ; et al. | 2018-07-19 |
Depot Preparation Containing Citric Acid Ester
App 20180185489 - MIYAZAKI; Tatsuya ; et al. | 2018-07-05 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20180169079 - SHAMS; Naveed ; et al. | 2018-06-21 |
Ocular Instillation Assisting Tool
App 20180168862 - YAMADA; Hiroshi | 2018-06-21 |
Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
Grant 9,999,594 - Kido , et al. June 19, 2 | 2018-06-19 |
Method and composition for treating ocular hypertension and glaucoma
Grant 9,999,593 - Reunamaki , et al. June 19, 2 | 2018-06-19 |
Intraocular lens injector
Grant 9,987,128 - Wagner , et al. June 5, 2 | 2018-06-05 |
Pharmaceutical composition comprising polypeptide
Grant 9,987,368 - Miyazaki , et al. June 5, 2 | 2018-06-05 |
Therapeutic Agent For Dry Eye Characterized By Being Applied To Eye Of Dry Eye Patient Wearing Soft Contact Lens
App 20180147230 - OSHITA; Yoshihiro ; et al. | 2018-05-31 |
Depot Formulations
App 20180117016 - TAMRAZ; Wilma ; et al. | 2018-05-03 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant 9,943,510 - Shams , et al. April 17, 2 | 2018-04-17 |
Dry Eye Therapeutic Agent Comprising Nandrolone Or Ester Thereof Or Methenolone Or Ester Thereof As An Active Ingredient
App 20180071313 - ENDO; Kenichi ; et al. | 2018-03-15 |
Pharmaceutical Composition Comprising Polypeptide
App 20180064818 - MIYAZAKI; Tatsuya ; et al. | 2018-03-08 |
2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluorometh- oxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
Grant 9,902,698 - Niwa , et al. February 27, 2 | 2018-02-27 |
Sustained-release Pharmaceutical Composition
App 20180042907 - OKABE; Komei ; et al. | 2018-02-15 |
Therapeutic Agent For Meibomian Dysfunction
App 20180021314 - MIYAKE; Hideki ; et al. | 2018-01-25 |
Polyaphrons And Palpebral Administration Thereof
App 20180015166 - SCHMITT; Mathieu ; et al. | 2018-01-18 |
Depot Formulations
App 20180000729 - TAMRAZ; Wilma ; et al. | 2018-01-04 |
Aqueous Ophthalmic Solution
App 20170348344 - INAGAKI; Koji ; et al. | 2017-12-07 |
Ophthalmic Aqueous Composition
App 20170340644 - ENDO; Yoko ; et al. | 2017-11-30 |
Intraocular lens injector
Grant 9,827,139 - Wagner , et al. November 28, 2 | 2017-11-28 |
Eye Drop Container Having Identifying Indicia
App 20170312174 - Azuma; Yoshiyuki | 2017-11-02 |
Intraocular Lens Injector
App 20170304046 - Ueno; Katsuyuki | 2017-10-26 |
Rapamycin Formulations And Methods Of Their Use
App 20170266109 - MUDUMBA; Sreenivasu ; et al. | 2017-09-21 |
Production Method For 3,3-dimethyl-3,4-dihydro-1h-quinoxalin-2-one Derivative And Intermediate For Said Production Method
App 20170247342 - KUDOU; Kazuhiro ; et al. | 2017-08-31 |
Prophylactic Or Therapeutic Agent For A Posterior Ocular Disease
App 20170202845 - YOSHIDA; Atsushi | 2017-07-20 |
Therapeutic Agent For Keratoconjunctive Disorder
App 20170182085 - KANEKO; Shinichiro ; et al. | 2017-06-29 |
Intraocular lens
Grant D790,707 - Doraiswamy , et al. June 27, 2 | 2017-06-27 |
Production method for 3,3-dimethyl-3,4-dihydro-1H-quinoxalin-2-one derivative and intermediate for said production method
Grant 9,676,703 - Kudou , et al. June 13, 2 | 2017-06-13 |
Fixed amount discharge container
Grant 9,669,988 - Kojima , et al. June 6, 2 | 2017-06-06 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluorometh- Oxy)phenyl]-3-pyridinecarboxamide Benzenesulfonate, Crystal Of Same, Crystal Polymorph Thereof, And Methods For Production Thereof
App 20170081286 - NIWA; Masashi ; et al. | 2017-03-23 |
Therapeutic Or Preventive Agent For Meibomian Gland Dysfunction Or Meibomian Gland Blockage
App 20170071852 - KIDO; Kazutaka ; et al. | 2017-03-16 |
Prophylactic or therapeutic agent for posterior ocular disease containing tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine derivative as effective ingredient
Grant 9,579,309 - Yoshida , et al. February 28, 2 | 2017-02-28 |
Mtor Pathway Inhibitors For Treating Ocular Disorders
App 20170049786 - NIVAGGIOLI; Thierry ; et al. | 2017-02-23 |
Liquid Formulations For Treatment Of Diseases Or Conditions
App 20170020809 - MUDUMBA; Sreenivasu ; et al. | 2017-01-26 |
Ophthalmic Solution Comprising Diquafosol
App 20170020910 - SAKATANI; Akiko ; et al. | 2017-01-26 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N[4-(trifluorometho- xy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
Grant 9,546,140 - Niwa , et al. January 17, 2 | 2017-01-17 |
Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
Grant 9,539,204 - Kido , et al. January 10, 2 | 2017-01-10 |
Method of ophthalmic surgery and kit therefor
Grant 9,539,138 - Tanaka January 10, 2 | 2017-01-10 |
Injector For Intraocular Lens
App 20160331587 - YAMADA; Yoshitaka ; et al. | 2016-11-17 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20160324838 - SHAMS; Naveed ; et al. | 2016-11-10 |
Ophthalmic solution comprising diquafosol
Grant 9,486,529 - Sakatani , et al. November 8, 2 | 2016-11-08 |
Pyridylaminoacetic Acid Compound And Polyoxyethylene Castor Oil-containing Pharmaceutical Composition
App 20160317512 - ENDO; Yoko | 2016-11-03 |
Pharmaceutical Composition Containing Pyridylaminoacetic Acid Compound
App 20160317664 - ENDO; Yoko | 2016-11-03 |
Rapamycin Formulations And Methods Of Their Use
App 20160303093 - MUDUMBA; Sreenivasu ; et al. | 2016-10-20 |
Injectible Agent And Depot Formation Method
App 20160303240 - OKI; Kenji ; et al. | 2016-10-20 |
Formulations and methods for vascular permeability-related diseases or conditions
Grant 9,452,156 - Kleinman , et al. September 27, 2 | 2016-09-27 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluorometh- Oxy)phenyl]-3-pyridinecarboxamide Benzenesulfonate, Crystal Of Same, Crystal Polymorph Thereof, And Methods For Production Thereof
App 20160251314 - NIWA; Masashi ; et al. | 2016-09-01 |
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Grant 9,415,038 - Shams , et al. August 16, 2 | 2016-08-16 |
Composition For Treating Or Preventing Glaucoma Comprising A Sulfonamide Compound And Another Drug
App 20160228421 - KIRIHARA; Tomoko ; et al. | 2016-08-11 |
Polyethylene Glycol-containing Composition
App 20160228420 - Murai; Kenji ; et al. | 2016-08-11 |
Production Method For 3,3-dimethyl-3,4-dihydro-1h-quinoxalin-2-one Derivative And Intermediate For Said Production Method
App 20160200690 - KUDOU; Kazuhiro ; et al. | 2016-07-14 |
Rapamycin formulations and methods of their use
Grant 9,387,165 - Mudumba , et al. July 12, 2 | 2016-07-12 |
Liquid formulations for treatment of diseases or conditions
Grant 9,381,153 - Mudumba , et al. July 5, 2 | 2016-07-05 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluorometh- oxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
Grant 9,359,328 - Niwa , et al. June 7, 2 | 2016-06-07 |
Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist
Grant 9,339,496 - Kirihara , et al. May 17, 2 | 2016-05-17 |
Ophthalmic Solutions
App 20160106757 - MORISHIMA; Kenji ; et al. | 2016-04-21 |
Intraocular lens implantation device
Grant D754,331 - Wargner , et al. April 19, 2 | 2016-04-19 |
Sealing Label with Identification Function and Container Wrapped with said Sealing Label
App 20160090224 - Azuma; Yoshiyuki | 2016-03-31 |
Therapeutic Agent For Meibomian Gland Dysfunction
App 20160022648 - MIYAKE; Hideki ; et al. | 2016-01-28 |
Operation-guiding cylinder for intraocular lens implantation device
Grant D748,256 - Wagner , et al. January 26, 2 | 2016-01-26 |
Lens-holding and guiding implement for intraocular lens implantation device
Grant D747,806 - Wargner , et al. January 19, 2 | 2016-01-19 |
Prophylactic Or Therapeutic Agent For Posterior Ocular Disease Containing Tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine Derivative As Effective Ingredient
App 20160008333 - YOSHIDA; Atsushi ; et al. | 2016-01-14 |
Intraocular Lens Injector
App 20150327992 - Wagner; Christian Winfried ; et al. | 2015-11-19 |
Container for intraocular lens
Grant D743,031 - Doraiswamy , et al. November 10, 2 | 2015-11-10 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluorometh- Oxy)phenyl]-3-pyridinecarboxamide Benzenesulfonate, Crystal Of Same, Crystal Polymorph Thereof, And Methods For Production Thereof
App 20150291560 - NIWA; Masashi ; et al. | 2015-10-15 |
Therapeutic Or Prophylactic Agent For Retinopathy Of Prematurity, Testing Method For Retinopathy Of Prematurity, And Screening Method For Therapeutic Or Prophylactic Substance For Retinopathy Of Prematurity
App 20150276718 - Matsuda; Hiroshi ; et al. | 2015-10-01 |
Intraocular Lens Injector
App 20150272779 - Wagner; Christian Winfried ; et al. | 2015-10-01 |
Formulations And Methods For Vascular Permeability-related Diseases Or Conditions
App 20150265581 - KLEINMAN; David M. ; et al. | 2015-09-24 |
Method for protecting a retinal neuronal cell
Grant 9,138,438 - Ishida , et al. September 22, 2 | 2015-09-22 |
Intraocular lens implantation device
Grant D739,010 - Wargner , et al. September 15, 2 | 2015-09-15 |
Therapeutic Or Preventive Agent For Meibomian Gland Dysfunction Or Meibomian Gland Blockage
App 20150245994 - Kido; Kazutaka ; et al. | 2015-09-03 |
Intraocular lens holder
Grant D737,957 - Wargner , et al. September 1, 2 | 2015-09-01 |
Intraocular lens implantation device
Grant D737,430 - Wargner , et al. August 25, 2 | 2015-08-25 |
Hair growth promoting agent containing 15,15-difluoroprostaglandin F.sub.2.alpha. derivative as active ingredient
Grant 9,089,720 - Ropo July 28, 2 | 2015-07-28 |
Pharmaceutical Formulations Comprising A Pyridylaminoacetic Acid Compound
App 20150196541 - Shams; Naveed ; et al. | 2015-07-16 |
Compound having PARP inhibitory activity
Grant 9,062,061 - Honda , et al. June 23, 2 | 2015-06-23 |
Liquid Formulations For Treatment Of Diseases Or Conditions
App 20150150794 - MUDUMBA; Sreenivasu ; et al. | 2015-06-04 |
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluorometh- oxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof
Grant 9,029,398 - Niwa , et al. May 12, 2 | 2015-05-12 |
3-hydroxy-6H-benzo [C] chromene-6-one derivative and manufacturing method thereof
Grant 9,029,572 - Kudou , et al. May 12, 2 | 2015-05-12 |
Intraocular lens
Grant D729,390 - Doraiswamy , et al. May 12, 2 | 2015-05-12 |
Method For Changing Condition Of Eyelid Of Hairless Animal
App 20150125394 - Miyake; Hideki ; et al. | 2015-05-07 |
Method For Changing Condition Of Eyelid By Administering Complete Freund's Adjuvant
App 20150125395 - Miyake; Hideki ; et al. | 2015-05-07 |
Intraocular lens
Grant D728,789 - Doraiswamy , et al. May 5, 2 | 2015-05-05 |
Agent for treatment of dry eye characterized by combining P2Y.sub.2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y.sub.2 receptor agonist and hyaluronic acid or salt thereof
Grant 9,006,208 - Shichijo , et al. April 14, 2 | 2015-04-14 |
Cap for packaging container
Grant D724,430 - Tahara , et al. March 17, 2 | 2015-03-17 |
Composition For Hair Growth
App 20150073005 - Shimazaki; Atsushi ; et al. | 2015-03-12 |
Ophthalmic Solution Comprising Diquafosol
App 20150072951 - Sakatani; Akiko ; et al. | 2015-03-12 |
1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity
Grant 8,975,256 - Matsuda , et al. March 10, 2 | 2015-03-10 |
Nozzle for packaging container
Grant D721,959 - Yamada , et al. February 3, 2 | 2015-02-03 |
Intraocular lens
Grant 8,940,045 - Doraiswamy , et al. January 27, 2 | 2015-01-27 |
Nozzle for packaging container
Grant D721,580 - Yamada , et al. January 27, 2 | 2015-01-27 |
Eye Drops
App 20150018287 - NAKAMURA; Takahiro ; et al. | 2015-01-15 |
Non-aqueous Liquid Composition
App 20150011518 - Yamada; Kazuhito ; et al. | 2015-01-08 |
Liquid formulations for treatment of diseases or conditions
Grant 8,927,005 - Mudumba , et al. January 6, 2 | 2015-01-06 |
Industrial Process For Preparation Of 1,2-dihydroquinoline Derivative Or A Salt Thereof, And Intermediate For Preparation Thereof
App 20140371459 - Yamamoto; Noriyoshi ; et al. | 2014-12-18 |
Method for treating a TRPV1-mediated disease
Grant 8,901,155 - Oki , et al. December 2, 2 | 2014-12-02 |
Nozzle for packaging container
Grant D718,129 - Yamada , et al. November 25, 2 | 2014-11-25 |
Eye drops
Grant 8,865,654 - Nakamura , et al. October 21, 2 | 2014-10-21 |
3-hydroxy-6h-benzo [c] Chromene-6-one Derivative And Manufacturing Method Thereof
App 20140296540 - KUDOU; Kazuhiro ; et al. | 2014-10-02 |
Cap for packaging container
Grant D712,265 - Tahara , et al. September 2, 2 | 2014-09-02 |
Novel Compound Having Parp Inhibitory Activity
App 20140243320 - Honda; Takahiro ; et al. | 2014-08-28 |
Inhibitor For Corneal Epithelial Cell Death, Inhibitor Characterized By Combining Hyaluronic Acid And Flavin Adenine Dinucleotide
App 20140228425 - Sakamoto; Asuka ; et al. | 2014-08-14 |
3-hydroxy-6H-benzo [c] chromene-6-one derivative and manufacturing method thereof
Grant 8,802,869 - Kudou , et al. August 12, 2 | 2014-08-12 |
Ophthalmic Solution Comprising Diquafosol, Method For Producing The Same, And Method For Inhibiting Formation Of Insoluble Precipitate
App 20140221306 - Sakatani; Akiko ; et al. | 2014-08-07 |
Rapamycin Formulations And Methods Of Their Use
App 20140194461 - MUDUMBA; Sreenivasu ; et al. | 2014-07-10 |
Intraocular lens
Grant 8,758,435 - Doraiswamy , et al. June 24, 2 | 2014-06-24 |
Container for intraocular lens
Grant D707,821 - Doraiswamy , et al. June 24, 2 | 2014-06-24 |
Holder for intraocular lens
Grant D704,832 - Patel , et al. May 13, 2 | 2014-05-13 |
Holder for intraocular lens
Grant D704,833 - Finney , et al. May 13, 2 | 2014-05-13 |
Holder for intraocular lens
Grant D704,831 - Buck , et al. May 13, 2 | 2014-05-13 |
Holder for intraocular lens
Grant D704,830 - Buck , et al. May 13, 2 | 2014-05-13 |
Fixed Amount Discharge Container
App 20140124542 - Kojima; Takashi ; et al. | 2014-05-08 |
Holder for intraocular lens
Grant D704,331 - Patel , et al. May 6, 2 | 2014-05-06 |
Pharmaceutical composition for improving intestinal absorption
Grant 8,686,006 - Umeda , et al. April 1, 2 | 2014-04-01 |
Ophthalmic Solution Containing Hyaluronic Acid Or Salt Thereof And Propylene Glycol
App 20140088039 - Inagaki; Koji ; et al. | 2014-03-27 |
Formulations for treating ocular diseases and conditions
Grant 8,663,639 - Dor , et al. March 4, 2 | 2014-03-04 |
Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent
Grant 8,664,221 - Kato , et al. March 4, 2 | 2014-03-04 |
Stable formulations, and methods of their preparation and use
Grant 8,658,667 - Mudumba , et al. February 25, 2 | 2014-02-25 |
Intraocular lens
Grant D699,851 - Doraiswamy , et al. February 18, 2 | 2014-02-18 |
Method For Treating An Inflammatory Disease By Administering A 1,2,3,4-tetrahydroquinoxaline Compound Containing A Phenyl Group Having A Sulfonic Acid Ester Structure Introduced Therein As A Substituent
App 20140045842 - KATO; Masatomo ; et al. | 2014-02-13 |
Rapamycin formulations and methods of their use
Grant 8,637,070 - Mudumba , et al. January 28, 2 | 2014-01-28 |
Combination Of Sulfonamide Compound And Tafluprost
App 20140018350 - KIRIHARA; Tomoko ; et al. | 2014-01-16 |
Combination Of Sulfonamide Compound
App 20140018396 - KIRIHARA; Tomoko ; et al. | 2014-01-16 |
Stable Formulations, And Methods Of Their Preparation And Use
App 20140011834 - Mudumba; Sreenivasu ; et al. | 2014-01-09 |
3-hydroxy-6h-benzo [c] Chromene-6-one Derivative And Manufacturing Method Thereof
App 20130310576 - Kudou; Kazuhiro ; et al. | 2013-11-21 |
1,2,3,4-tetrahydroquinoxaline Compounds Having Glucocorticoid Receptor Binding Activity
App 20130303537 - MATSUDA; Mamoru ; et al. | 2013-11-14 |
Method for treating a disease related to the glucocorticoid receptor
Grant 8,580,784 - Matsuda , et al. November 12, 2 | 2013-11-12 |
Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound
Grant 8,569,493 - Matsuda , et al. October 29, 2 | 2013-10-29 |
Method for preventing or treating a disease related to the glucocorticoid receptor
Grant 8,563,551 - Matsuda , et al. October 22, 2 | 2013-10-22 |
Comprehensive Glaucoma Determination Method Utilizing Glaucoma Diagnosis Chip And Deformed Proteomics Cluster Analysis
App 20130275349 - Tashiro; Kei ; et al. | 2013-10-17 |
1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
Grant 8,551,991 - Matsuda , et al. October 8, 2 | 2013-10-08 |
Intraocular lens
Grant D691,273 - Doraiswamy , et al. October 8, 2 | 2013-10-08 |
Method for treating a keratoconjunctival disorder
Grant 8,536,207 - Yoshida , et al. September 17, 2 | 2013-09-17 |
Intraocular lens
Grant D689,611 - Doraiswamy , et al. September 10, 2 | 2013-09-10 |
Intraocular lens
Grant D688,800 - Doraiswamy , et al. August 27, 2 | 2013-08-27 |
Intraocular lens
Grant D688,801 - Doraiswamy , et al. August 27, 2 | 2013-08-27 |
Compounds having 4-pyridylalkylthio group as a substituent
Grant 8,518,973 - Honda , et al. August 27, 2 | 2013-08-27 |
Cyclic compound having pyrimidinylalkylthio group
Grant 8,507,485 - Tajima , et al. August 13, 2 | 2013-08-13 |
Stable formulations, and methods of their preparation and use
Grant 8,492,400 - Mudumba , et al. July 23, 2 | 2013-07-23 |
Formulations and methods for vascular permeability-related diseases or conditions
Grant 8,486,960 - Kleinman , et al. July 16, 2 | 2013-07-16 |
Intraocular lens
Grant D685,477 - Doraiswamy , et al. July 2, 2 | 2013-07-02 |
Indole derivative having, carbamoyl group, ureido group and substituted oxy group
Grant 8,445,529 - Kawashima , et al. May 21, 2 | 2013-05-21 |
Method for treating a disease related to the glucocorticoid receptor
Grant 8,440,660 - Matsuda , et al. May 14, 2 | 2013-05-14 |
Method for determination of progression risk of glaucoma
Grant 8,431,345 - Kinoshita , et al. April 30, 2 | 2013-04-30 |
Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
Grant 8,426,406 - Kato , et al. April 23, 2 | 2013-04-23 |
Method for preventing or treating a glucocorticoid receptor-related disease
Grant 8,420,635 - Matsuda , et al. April 16, 2 | 2013-04-16 |
Liquid formulations for treatment of diseases or conditions
Grant 8,367,097 - Mudumba , et al. February 5, 2 | 2013-02-05 |
Formulations And Methods For Vascular Permeability-related Diseases Or Conditions
App 20120329759A1 - | 2012-12-27 |
Method for treating age-related macular degeneration
Grant 8,309,612 - Hirai , et al. November 13, 2 | 2012-11-13 |
Thiophenediamine derivative having urea structure
Grant 8,288,380 - Mogi , et al. October 16, 2 | 2012-10-16 |
Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
Grant 8,252,945 - Seike , et al. August 28, 2 | 2012-08-28 |
Methods for treating a disease in which Rho kinase is involved
Grant 8,232,308 - Hagihara , et al. July 31, 2 | 2012-07-31 |
Indazole derivative having spiro ring structure in side chain
Grant 8,227,480 - Hagihara , et al. July 24, 2 | 2012-07-24 |
Method for treating a keratoconjunctival disorder
Grant 8,222,283 - Yoshida , et al. July 17, 2 | 2012-07-17 |
| 